Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · IEX Real-Time Price · USD
0.440
-0.031 (-6.56%)
At close: Jul 19, 2024, 4:00 PM
0.409
-0.031 (-7.07%)
Pre-market: Jul 22, 2024, 7:22 AM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $3.39 million as of July 22, 2024. Its market cap has decreased by -68.02% in one year.
Market Cap
3.39M
Enterprise Value
-1.65M
1-Year Change
-68.02%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.80M to $3.39M, a decrease of -97.91%. That is a compound annual growth rate of -38.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.80M | -43.75% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.35% |
| Dec 31, 2021 | 38.50M | -74.65% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.32% |
| Dec 29, 2017 | 90.90M | 84.01% |
| Dec 30, 2016 | 49.40M | -69.47% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scinai Immunotherapeutics | 3.51M |
| Enveric Biosciences | 3.50M |
| Lipella Pharmaceuticals | 3.50M |
| Fresh2 Group | 3.45M |
| Portage Biotech | 3.43M |
| Protagenic Therapeutics | 3.38M |
| Aditxt | 3.35M |
| Ensysce Biosciences | 3.31M |